Back to Journals

Biosimilars ceased publishing in October 2016. All new submissions can be made to Biologics: Targets and Therapy. All articles that have been published in Biosimilars will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.


ISSN: 2230-245X

An international, peer reviewed, open access journal focusing on the manufacture, development, and medicinal use of biopharmaceutical compounds considered similar to an innovator agent.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Indexed online: